Trovagene's Foray Into The Conventions Of Molecular Diagnostics Seeking Alpha Furthermore, adoption of Trovagene's products is not limited to early diagnosis, but according to the company, will include cancer monitoring, detecting transplant rejection, screening for genetic risks in pregnant mothers, and infectious disease ... |
